2026-08-17 from citynews.ca
Health Canada has authorized a drug to treat moderate to severe hot flashes and night sweats in breast cancer patients.
Elinzanetant, also known by the brand name Lynkuet, was first approved in July 2025 to treat the symptoms in women going through menopause, but another study reviewed by the department has since shown effectiveness of the drug specifically in breast cancer patients.
About two-thirds of breast cancers are hormone-receptor positive, meaning they need estrogen to grow. Oncologists treat those cancers by blocking the body’s production of estrogen, often triggering vasomotor symptoms such as hot flashes and night sweats.
Read more here